Piramal Pharma Solutions Opens Dedicated OSD Suite in U.S. to Support NewAmsterdam Pharma’s Cholesterol Therapy

The multi-million-dollar investment provides NewAmsterdam Pharma with commercial capacity for fixed dose combination (FDC) of obicetrapib and ezetimibe...

August 25, 2025 | Monday | News
What Makes Recombinant Proteins Crucial in Computational Biology

When it comes to the field of computational biology, rProteins and bioinformatics fit together almost like a lock and key.  Recombinant protein techn...

August 24, 2025 | Sunday | News
InnoCare Pharma Begins Registrational Study of Mesutoclax in China, Offering New Hope for Lymphoma Patients Globally

InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has...

August 22, 2025 | Friday | News
Thermo Fisher Opens Carbon-Neutral Manufacturing Center in North Carolina to Boost U.S. Pipette Tip Supply

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the grand opening of its innovative manufacturing center of excellenc...

August 22, 2025 | Friday | News
Alvotech and Advanz Pharma Secure European Commission Approval for Mynzepli®, a Biosimilar to Eylea®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

August 22, 2025 | Friday | News
Novocure Submits PMA to FDA for Tumor Treating Fields Therapy in Pancreatic Cancer

Novocure announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields...

August 21, 2025 | Thursday | News
Sanofi Advances Rare Disease Pipeline as Rilzabrutinib Gains EMA Orphan Status in IgG4-RD

Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025 Additional orphan desi...

August 18, 2025 | Monday | News
Regen BioPharma Advances HemaXellerate Toward Phase 1 Trials Following FDA Clearance

Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company&...

August 18, 2025 | Monday | News
Ascentage Pharma Receives FDA and EMA Clearance for Global Phase III Trial of Lisaftoclax in Higher-Risk MDS

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and c...

August 18, 2025 | Monday | News
Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News
Enable Injections Wins ANVISA Approval for enFuse® On-Body Drug Delivery System in Brazil

Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® on-body drug deliv...

August 14, 2025 | Thursday | News
Avobis Bio Seeks FDA RMAT Designation for AVB-114 Following Positive Phase II Results

Analysis leads to FDA RMAT submission and late-breaking abstract for implantable cell therapy - Avobis Bio LLC, a clinical stage company developing impl...

August 08, 2025 | Friday | News
Intas Strengthens Global Leadership in Pegfilgrastim with UDENYCA® Acquisition

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the worl...

August 08, 2025 | Friday | News
Axplora Announces €6.5 Million Expansion at Vizag Site Following Successful USFDA Inspections in India

Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production ca...

August 06, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close